Drugs in space: the pharmacy orbiting the Earth Researchers are busy developing pharmaceutical solutions for astronauts, but that extraterrestrial research could also have implications for how medicines are delivered on Earth.…
Heparin and zilucoplan added to COVID-19 ACCORD trials platform The National Institute for Health Research has confirmed that two more drugs will be included in a clinical trial scheme designed to speed up development of new medicines for patients hospitalised with COVID-19.…
Why we need to talk about sex and clinical trials The under-representation of women in clinical trials is slowly being addressed, but we cannot move towards truly personalised healthcare unless we have an equal balance of the sexes in all new medicine trials.…
Targeting COVID-19: the drugs being fast-tracked through clinical trials and how they work The NHS is rapidly enrolling patients into studies as part of a focused international effort to find medicines that will interfere with viral replication or help modulate the immune system response.…
The hunt for an effective treatment for COVID-19 As researchers around the globe drop everything to find a treatment for COVID-19, we look at the likely frontrunners for managing this deadly disease.…
Going against type: the new class of cancer therapies targeting mutations rather than tissues ‘Tumour agnostic’ drugs offer a more effective and tolerable therapy for a wide range of people with cancer, so why has the NHS rejected its first one?…
The race to stop COVID-19 As a new strain of coronavirus threatens public health systems across the globe, researchers are racing to develop a vaccine.…
Top ten most popular research briefings of 2019 Our research briefings are concise and informative; they keep readers up to date with the latest developments in science and clinical research — from novel uses for existing drugs, to studies assessing potential new treatments.…
Before the dawn: the tough regulatory climate holding back insomnia relief A new class of sleep medicines, could provide relief for people living with insomnia, but pharmaceutical companies are struggling to bring them to the market.…
The precision medicine approach to cancer therapy: part 1 — solid tumours An overview of the anticancer agents that have been approved for use in the UK as part of a precision medicine approach for solid tumours, along with information relating to the relevant biomarkers and biomarker assays currently available.…
